Incoming Chief Executive William Weldon , who takes over on April 25, will inherit a pharmaceuticals powerhouse.

FORBES: Johnson & Johnson Earnings Jump On Drugs

He split medical devices and drugs into two separate divisions and named a rising star, William Weldon, 53, to run the drug side.

FORBES: J&J An unfinished symphony

The House Committee on Oversight and Government Reform also invited Johnson and Johnson Chief Executive William Weldon, but he declined to attend because of health reasons.

CNN: STORY HIGHLIGHTS